RRML - Pathogenic intronic and deleterious benign variants: two extremes in cancer predisposition molecular diagnosis
AMLR

ISSN online: 2284-5623

ISSN-L: 1841-6624

Rejection rate (2020): 75%

Română English

Journal Metrics

Impact Factor 0.5
Five Year Impact Factor 0.5
JCI 0.12

Advanced search

Top 10 downloaded articles
- October 2025 -
 
Polymorphisms in FVL, prothrom... 9
Comparison of platelet suspens... 9
Romanian Review of Laboratory ... 7
Plasma phosphorylated neurofil... 7
Investigation of cytokine chan... 7
Oxidative stress in preeclamps... 7
Serum fibronectin and C-reacti... 6
Association of ischemia-modifi... 6
Anti-thyroid peroxidase (TPO) ... 6
Correlations of vascular cogni... 6

Log in

Concept, Design & Programming
Dr. Adrian Man
   
 
Nr. 20(4)/2012
XML
TXT

Pathogenic intronic and deleterious benign variants: two extremes in cancer predisposition molecular diagnosis

Lucian Negură, Anca Negură, Andrei Coneac, Ioana Berindan Neagoe, Doina Azoicăi, Alexandru Irimie


Abstract:

Molecular diagnosis in cancer predisposition is today current practice in Western Europe, which allows oncogenetic follow-up of patients and their families. Diagnosis is mainly targeting BRCA, MMR and APC genes, involved in hereditary breast and ovarian cancer syndrome (HBOC), hereditary non-polyposic colorectal cancer or Lynch syndrome (HNPCC), and familial adenomatous polyposis (FAP) respectively. Carriers of deleterious mutations in any of these genes are at significantly higher risk of developing cancer than general population. Thousands of BRCA sequence variations have already been reported, but not all variants can be considered pathological. Deleterious mutations and common non-pathogenic single nucleotide polymorphisms are usually detected, but almost a half of the observed variations are of uncertain clinical significance. In-silico analysis including sequence alignments, tolerance prediction and splicing analysis is therefore essential for understanding possible effects on protein function and pathogenicity. While completely sequencing BRCA1 and BRCA2 genes in routine molecular diagnosis, we found several unclassified variants which easily can blur analysis, either being false-positive or false-negative. We show here that extreme examples such as pathogenic intronic and deleterious benign variants represent real challenges in molecular diagnosis. Good experience, a lot of attention and responsibility are essential in order to avoid errors.

Keywords: molecular diagnosis,unclassified variants,in-silico analysis,false positives,false negatives.

 
  PDF Download full text PDF
(685 KB)
     
 
How to cite
Negură L, Negură A, Coneac A, Berindan Neagoe I, Azoicăi D, Irimie A. Pathogenic intronic and deleterious benign variants: two extremes in cancer predisposition molecular diagnosis. Rev Romana Med Lab. 2012;20(4):317-26